C3 and myeloid sarcoma: The upregulation of complement components C1q, C3b, C4d, C3aR, and C5aR C5b-9 (MAC) was also evident in postmortem human tissue and in preclinical models of MS, suggesting the involvement of classical and alternative pathways [175,176,177].